Clinical trial NCT04516889: Evaluating Safety and Efficacy of a Modified Technique of Scleral Fixation Intraocular Lens Implantation
Official title: Evaluating Safety and Efficacy of a Modified Technique of Scleral Fixation Intraocular Lens Implantation
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Aphakia
Cataract
Lead sponsor: Chinese University of Hong Kong
Sponsor class: OTHER
First posted: 2020-08-18
Enrollment: 39
Sex: ALL
Minimum age (years): 18
Maximum age (years): 99
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: Cataract is the leading cause of blindness globally and cataract surgery with the implantation of intraocular lens (IOL) is the most commonly performed operation worldwide. After removal of the cataract, an IOL is usually implanted within the capsular bag. However, endocapsular implantation of IOL is not always feasible due to inadequate zonular or capsular support, intraoperative posterior capsule rupture, or in primary intracapsular cataract extraction. Predisposing factors including prior ocular trauma, intravitreal injection or intraocular surgery, co-existing ocular comorbidities like chronic uveitis, pseudoexfoliation syndrome, may increase the risk of failure of in-the-bag implantation.

In such situation, the surgeons may consider implanting the IOL in the anterior chamber, ciliary sulcus, or using fixation techniques. In Asian eyes, the anterior chambers are often shallow and placement in anterior chamber may accelerate corneal endothelial cell loss leading to corneal decompensation, or worsen pre-existing glaucoma. Placement in the ciliary sulcus depends on the amount and integrity of the capsular remnant, and inadequate support may result in dislocation of the IOL. In recent years, newer forms of scleral fixation of IOL using glue or glue-less approach, although these procedure appeared to be simpler, the long-term stability of these IOL have not been evaluated against conventional approach with suture fixation. The main limitations of suture fixation technique are related to the sutures either intraoperatively (e.g. entanglement, failure to rotate and bury the suture knot) or postoperatively (breakage, dissolution of suture with time), and the learning curve required for surgeons in training.

Our study aims to study the efficacy and safety of a modified technique of scleral fixation of an intraocular lens in the posterior chamber.


Eligibility criteria: Inclusion Criteria:

* Adult patients with phacodonesis, lens subluxation, insufficient capsular or zonular support, or surgical aphakia without adequate ciliary sulcus who are listed for scleral fixation intraocular lens implantation.

Exclusion Criteria:

* Patients with previous corneal transplantation surgery or undergoing concomitant corneal transplantation at the time of scleral fixation intraocular lens implantation.
* Patients undergoing concomitant vitreoretinal surgery at the time of intraocular lens implantation.
* Monocular patients, or patients whose fellow eye had vision of equal or less than 20/200.
* Patients who could not comprehend the risks and benefits of the surgery and/or the research study, including mentally incapacitated persons.
* Patients with pre-existing macular pathologies including macular oedema, haemorrhage, degeneration or scar.
* Patients with pre-existing iris abnormalities including aniridia, corectopia, extensive anterior synechiae formation resulting in inability to measure the IOL tilting postoperatively.
* Patients with significantly reduced corneal endothelial cell density (of \< 1000 cells/mm2) preoperatively which may necessitate a corneal transplantation.

Primary outcomes:
measure: Proportion of eyes with intraoperative, early (within 1 week) and late (at 12 months) postoperative complications following this modified technique of intraocular lens fixation.
timeFrame: up to 12 months
Secondary outcomes:
measure: Unaided and corrected visual acuities
timeFrame: up to 12 months
measure: Intraocular lens tilting
timeFrame: up to 12 months
measure: endothelial cell status
timeFrame: up to 12 months
Other outcomes:
Locations:
Study officials:
affiliation: Prince of Wales Hospital
name: Alvin L Young
role: PRINCIPAL_INVESTIGATOR
References: